Search
This study contributes to our understanding of the genetic diversity of NMC, an important step towards finding therapeutic targets for a disease that is...
Brain tumors presenting in infancy, especially during the first 6 months of life.
Acute Lymphoblastic Leukemia (ALL) occurring in the first year of life is rare.
Genotyping has become more cost-effective and less invasive with the use of buccal cell...
Our data shows that the expression of distinct IFNα subtypes within the tumor microenvironment results in different anti-tumor activities
The aim of our study was to investigate whether CBL0137 has potential as a therapeutic and chemopotentiating compound in MLL-r leukemia
In response to DNA damaging chemotherapy, targeting MK2 in p53-mutated cells produces a phenotype that is distinct from the p53-deficient phenotype
In this review we explore the current literature about the predictive characteristics of the tumor microenvironment and discuss therapeutic approaches
Our findings highlight the potential of salinomycin to induce DNA lesions and inhibit homologous recombination to greatly enhance the effect of radiotherapy
Our approach to hematopoietic progenitor cells mobilization resulted in highly effective HPC harvest in children and adolescents with high-risk cancers